Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
Results from a Phase 1 First in human Study of Pemivibart: an[...]
09/19/2024 | Press release | Distributed by Public on 09/19/2024 14:39
Please select the service you want to use:
Smartlinks | Illinois Courts | State of Illinois | News | Crime and Judiciary | Judiciary | Criminal Law | Politics and Policy | Government | Local Government | Judiciary | Criminal Law | Courts and Tribunals
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact